Instalab
logoInstalab

Total Globulin

A routine blood calculation that can catch antibody loss on the low end and immune or liver stress on the high end.
4.9 (3,681 reviews)
Tested by Quest, Access Medical or Boston Heart
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Total Globulin test?

This test is most useful if any of these apply to you.

Healthy but Reading Your Own Labs
You want the protein number total protein can hide: low can point to antibody loss, high to immune or liver stress.
Catching Infections Again and Again
Frequent sinus, lung, or ear infections make antibody levels worth checking, and globulin is a cheap first clue.
On Long-Term Steroids or Immune Drugs
Steroids, rituximab, and similar drugs can lower antibodies, so a falling value deserves a closer look.
Watching Your Liver or Inflammation
A rising value can add context when liver disease or chronic inflammation is on the table.

About Total Globulin

Total globulin is a quiet number on a standard blood panel, and almost no one looks at it. It is a rough signal from antibodies, inflammation proteins, and liver-made transport proteins. When it drifts, the reason is not always obvious at first.

A low value can be the first hint of an antibody shortage that leaves you catching infection after infection. A high value can be a clue to chronic inflammation, liver disease, or a plasma-cell disorder. Either can be missed if you only glance at total protein.

What Total Globulin Actually Measures

Total globulin is a pooled number. It includes hundreds of non-albumin blood proteins. Antibodies are a large part of the pool. Antibodies are also called immunoglobulins. The rest includes transport proteins, clotting proteins, and inflammation proteins made mostly by your liver.

Labs usually do not measure globulin directly. They measure total protein and albumin, then subtract one from the other: total protein minus albumin equals globulin. That is why it is sometimes printed as calculated globulin. It is cheap, and it is included in many metabolic panels.

Because antibodies make up a large share of the value, the number can move when antibody production changes. Broad immune activation can push it up. Failing antibody production can pull it down. Liver disease can push it up or down depending on which proteins are changing.

When Globulin Runs Low

A low globulin is easy to dismiss and shouldn't be. The reason it matters: it can flag hypogammaglobulinemia, a shortage of antibodies that leaves you open to repeated bacterial infections, especially of the lungs and sinuses. This kind of deficiency often goes unnamed for years while damage builds.

In hospitalized patients, a very low calculated globulin reflected true low IgG, the main antibody class, in about 8 out of 10 people. As a cheap way to catch a possible deficiency early, that is a useful signal.

The catch is that this screen misses most deficiency, flagging only about 6 out of 100 people who actually have low antibody levels. So a low result is worth confirming; a normal result is reassuring but not proof. Other causes of a low value include protein lost through diseased kidneys or gut, malnutrition, and a liver that can no longer make enough protein.

When Globulin Runs High

A high globulin is more common and usually reactive rather than sinister. In primary care the most common cause is liver disease, especially cirrhosis and other chronic liver disorders. Chronic inflammation and autoimmune diseases such as rheumatoid arthritis, lupus, and vasculitis can drive it higher through a broad rise in antibodies. Long-running infections can do the same.

The higher it climbs, the more the odds shift. In a hospitalized cohort with markedly high calculated globulin, the causes broke down as liver disease 37%, blood cancers 36%, autoimmune disease 13%, and infections 9%. Among high results that were worked up with electrophoresis, about 42% had an abnormal single-clone protein, the kind seen in myeloma and related disorders.

For most people a mildly high value with normal liver enzymes points more toward broad immune activation than cancer. But a very high number, or one that looks like it comes from a single antibody clone, is worth separating out with protein electrophoresis. That test splits the globulins into bands.

Why Both Directions Carry Risk

This is a two-sided immune gauge. Too little can mean you cannot defend yourself well. Too much usually means something is provoking your immune system around the clock. A healthy pattern is not the lowest possible number. It is enough antibody without constant immune stimulation.

What the Albumin-to-Globulin Ratio Adds

Pairing globulin with albumin sharpens the picture. The albumin-to-globulin ratio, often printed as A/G, falls when albumin drops, globulin rises, or both. A low ratio has predicted hard outcomes even in people who feel well.

In a study of about 27,000 generally healthy adults, those with the lowest ratios were roughly 6.7 times as likely to die over the following years, and about 4 times as likely to be diagnosed with cancer, as those with the highest ratios. The cancer link held even after setting aside cancers found in the first two years, so it was not just picking up disease already present.

A separate 12-year community study of about 8,000 adults without kidney disease found that a low ratio predicted new chronic kidney disease better than white blood cell count or C-reactive protein, a common inflammation marker. The ratio is worth reading alongside the raw globulin number, not instead of it.

Signals in People Already at Risk

In several groups with existing disease, a higher globulin has tracked worse outcomes. The likely reason is that it marks ongoing inflammation.

Who Was StudiedWhat Was ComparedWhat They Found
About 104,000 people starting dialysisHigher versus lower globulinHigher globulin, modestly greater risk of dying
554 people on peritoneal dialysisAbove versus below the median globulinHigh globulin, about twice the risk of death
272 people with early cirrhosisHigher versus lower gamma globulinMore likely to develop liver cancer, liver worsening, and death over the years

Source: Pai et al. 2022 (hemodialysis); Hsieh et al. 2023 (peritoneal dialysis); Cacciola et al. 2018 (compensated cirrhosis).

If you already live with kidney disease or liver disease, a rising globulin is not background noise. It is a reason to look harder at what is fueling the inflammation, alongside the rest of your workup.

When a Single Reading Can Fool You

A few things can move one measurement without reflecting your baseline:

  • Recent infection or inflammation: antibodies and inflammation proteins climb during and after an illness, and can stay up for weeks. A value drawn soon after being sick can read high.
  • Dehydration: a concentrated blood sample makes total protein and calculated globulin look falsely elevated.
  • Recent surgery: globulin can swing in two directions over the first one to two weeks after an operation before settling.
  • Sample handling: a hemolyzed or fatty sample can distort total protein or albumin on some analyzers. Serum and plasma can also differ because plasma contains clotting proteins.

Why One Reading Isn't Enough

In a healthy person, antibody proteins are usually fairly stable. Studies of individual immunoglobulins show only small within-person variation over weeks. Calculated globulin is still affected by the total protein and albumin methods, so your trend is often more useful than one isolated value.

Get a baseline. If the result is out of pattern, repeat it when you are well and normally hydrated. A value that keeps drifting in one direction tells you far more than a single snapshot.

What to Do With an Out-of-Pattern Result

If globulin is low, measure the individual antibody classes: IgG, IgA, and IgM. That confirms whether the low value is really an antibody problem. Low antibodies plus repeated infections points toward involving an immunologist.

If it is high, pair it with liver enzymes and an inflammation marker like C-reactive protein. A markedly high value, or one that looks like it comes from a single antibody clone, calls for serum protein electrophoresis. If a single-clone band appears, hematology should rule out myeloma and related disorders. A mildly high globulin with normal liver enzymes and no symptoms usually earns watchful rechecking rather than an aggressive workup.

What Moves This Biomarker

Evidence-backed interventions that affect your Total Globulin level

↑ Increase
Immunoglobulin replacement therapy for confirmed antibody deficiency
This raises antibody levels directly and can raise calculated globulin when the low value is driven by low IgG. In a randomized crossover trial in lung transplant recipients with low IgG, monthly IVIG raised average IgG troughs from 486 to 765 mg/dL but did not reduce infections over three months. The biomarker effect is clear; clinical use depends on the cause of the deficiency and infection history.
MedicationStrong Evidence
↓ Decrease
Long-term or high-dose corticosteroids
Sustained steroid treatment can lower IgG by reducing antibody production and increasing antibody breakdown. The effect is measured most clearly as IgG, not total globulin, so calculated globulin may fall most when the antibody drop is large or when other globulin proteins are not rising from inflammation. Infection risk depends on dose, other immune-suppressing drugs, and whether low antibodies come with repeated infections.
MedicationStrong Evidence
↓ Decrease
B-cell depleting drugs and other immune-suppressing drugs
Drugs that deplete or suppress antibody-making cells, especially rituximab and related anti-CD20 drugs, can lower immunoglobulins and may pull calculated globulin down. In one lymphoma series, 38.5% of patients with normal baseline IgG developed low IgG after rituximab. Other immune-suppressing drugs can add to the risk, especially in combination.
MedicationStrong Evidence
↓ Decrease
Regular aerobic or strength training
Regularly active people tend to have slightly lower calculated globulin and lower C-reactive protein. In a cross-sectional analysis of 80,111 young adults, more days per week of aerobic or strength training went with lower globulin. Read this as a healthy pattern when your result is high from inflammation, not a goal to push globulin as low as possible.
ExerciseModest Evidence
↑ Increase
Heavy alcohol consumption
Heavy drinking raises IgA, one antibody class in the globulin fraction, so sustained heavy intake can raise calculated globulin, especially alongside liver disease. In a study of 460 adults, heavy drinkers had higher IgA after accounting for other factors, and the effect was strongest in people with metabolic problems. Heavy alcohol can lower IgG and IgM even as IgA rises, so the net change in total globulin depends on the balance of antibody classes. The rise reflects immune and liver irritation, not anything beneficial.
LifestyleModest Evidence
↑ Increase
Higher body weight
Higher weight is associated with higher globulin subfractions, tracking the low-grade inflammation that can come with excess body fat. In a study of 9,547 women, rising weight went with higher alpha, beta, and gamma globulins even as albumin fell. That pattern usually lowers the albumin-to-globulin ratio too.
LifestyleModest Evidence
↓ Decrease
Cigarette smoking
Smoking lowers IgG, one antibody class in the globulin fraction, so it can nudge calculated globulin down. In population studies, smokers had lower IgG after adjustment for other factors. Smoking also tends to raise IgA, so the net change in total globulin is smaller and less predictable than the change in IgG alone. The drop in IgG reflects a weaker antibody pattern, not a healthier one.
LifestyleModest Evidence

Frequently Asked Questions

References

25 studies
  1. Hoo T, Lim EM, John M, D'orsogna L, Mclean-tooke aAnnals of Clinical Biochemistry2021
  2. Jolles S, Borrell R, Zouwail SClinical and Experimental Immunology2014
  3. Zhao EJ, Cheng CV, Mattman a, Chen LYCThe Lancet Haematology2021
  4. Otani IM, Lehman HK, Jongco AMThe Journal of Allergy and Clinical Immunology2022